Optimization of Health before Surgery: Lessons from the ACS Strong for Surgery Program and Rethinking Clinical Care Models during the Pandemic

In this session of the annual William D. Seybold Distinguished Lectureship, Dr. Thomas Varghese discusses the American College of Surgeon's Strong for Surgery Quality Improvement Program, including: design principles, lessons learned, and ways in which surgical care has been impacted by the COVID-19 pandemic.

This Michael E. DeBakey Department of Surgery Grand Rounds session took place on Wednesday, March 31, 2021 at 7:00 A.M.

CME Information

CME Credit Available

You may claim CME credit after watching this activity.

You will be redirected to an outside site when claiming credit and may be asked to register or log in.

Needs Statement

General, plastic, thoracic, vascular, cardiothoracic, abdominal transplantation and surgical oncology physicians, residents, fellows and medical students need to be regularly updated on novel therapies, as well as advances in surgical care and clinical practices that will aid them in treating a variety of surgical procedures to increase the patient care experience and improve practice efficiency.

Objectives

At the conclusion of the session, the participants should be able to:

  • Identify and evaluate evidence-based practices to optimize the health of patients before surgery.
  • Explain the design principles of the American College of Surgeons Strong for Surgery quality program and summarize lessons learned from participating sites across the nation.
  • Discuss key factors in pre-surgical care that have been impacted by the COVID-19 pandemic.
  • Detail a vision for the future to improve surgical practices and population health.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

  1. James W. Suliburk, M.D., FACS

    James W. Suliburk, M.D., FACS

    Associate Professor and Chief, Endocrine Surgery
    Baylor College of Medicine

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenter

  1. Thomas K. Varghese, M.D., M.S., FACS

    Thomas K. Varghese, M.D., M.S., FACS

    Interim Executive Medical Director and Chief Value Officer
    Huntsman Cancer Institute, University of Utah

    Disclosure:

    Nothing to disclose.

Program Director

  1. James W. Suliburk, M.D., FACS

    James W. Suliburk, M.D., FACS

    Associate Professor and Chief, Endocrine Surgery
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Michele Loor, M.D., FACS

    Michele Loor, M.D., FACS

    Assistant Professor of Surgery
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  2. Todd Rosengart, M.D., F.A.C.S.

    Todd Rosengart, M.D., F.A.C.S.

    DeBakey-Bard Chair of Surgery
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  3. James W. Suliburk, M.D., FACS

    James W. Suliburk, M.D., FACS

    Associate Professor and Chief, Endocrine Surgery
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information Claim CME

You will be redirected to an outside site when claiming credit and may be asked to register or log in.

Presenter:

  1. Thomas K. Varghese, M.D., M.S., FACS

    Thomas K. Varghese, M.D., M.S., FACS

    Interim Executive Medical Director and Chief Value Officer Huntsman Cancer Institute, University of Utah